Neurotrophic Factors and Gene Therapy in Spinal Cord Injury

Neurorehabilitation and Neural Repair

Volumn 14, Issue 4, 2000, Pages 265-275

  Lacroix, Steve ^a,b   Tuszynski, Mark H ^b  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

Author keywords

Central nervous system; Cytokine; Neurotrophin; Regeneration; Stem cell

Indexed keywords

CYTOKINE; NEUROTROPHIC FACTOR; NEUROTROPHIN;

CELL SURVIVAL; CENTRAL NERVOUS SYSTEM; CONVALESCENCE; GENE TARGETING; GENE THERAPY; GLIA CELL; NERVE FIBER GROWTH; REVIEW; SCHWANN CELL; SPINAL CORD INJURY; STEM CELL;

ANIMALS; GENE THERAPY; HUMANS; NERVE GROWTH FACTORS; NERVE REGENERATION; SPINAL CORD INJURIES;

EID: 0034439622     PISSN: 15459683     EISSN: 15526844     Source Type: Journal    
DOI: 10.1177/154596830001400403     Document Type: Review

References (139)

1. Richards JS Go BK Rutt RD Lazarus PB. The national spinal cord injury collaborativedatabase. In: Stover SL DeLIsa JA Whiteneck GG,eds. Spinal cord injury: Clinical outcomes from model systems. Gaithersburg, MD: Aspen, 1995: 10–20.
2. Go BK DeVivo MJ Richards JS. The epidemiology of spinal cord injury. In: Stover SL DeLIsa JA Whiteneck GG,eds. Spinal cord injury: Clinical outcomes from model systems. Gaithersburg, MD: Aspen, 1995: 21–55.
3. Grill R Murai K Blesch A, et al Cellular delivery of neurotrophin-3 promotes corticospinal axonalgrowth and partial functional recovery after spinal cordinjury. J Neurosci 1997; 17: 5560–72.
4. David S Aguayo AJ. Axonal elongation into peripheral nervous system“bridges” after central nervous system injury in adultrats. Science 1981; 214: 931–3.
5. Levi-Montalcini R Hamburger V. Selective growth stimulating effects of mouse sarcoma on thesensory and sympathetic nervous system of the chick embryo. J Exp Zool 1951; 116: 321–62.
6. Levi-Montalcini R Hamburger V. A diffusible agent of mouse sarcoma, producing hyperplasia ofsympathetic ganglia and hyperneurotization of viscera in the chickembryo. J Exp Zool 1953; 123: 233–88.
7. Cohen S Levi-Montalcini R. Purification and properties of a nerve growth-promotingfactor isolated from mouse sarcoma. CancerRes 1957; 17: 15–20.
8. Levi-Montalcini R. The nerve growth factor 35 years later. Science 1987; 237: 1154–62.
9. Schwab ME. Myelin-associated inhibitors of neurite growth andregeneration in the CNS. Trends Neurosci 1990; 13: 452–6.
10. Thoenen H. Neurotrophins and neuronal plasticity. Science 1995; 270: 593–8.
11. Tuszynski MH Kordower J. CNS regeneration: Basic science and clinical advances. San Diego: Academic Press, 1999.
12. Snider WD. Functions of the neurotrophins during nervous systemdevelopment: What the knockouts are teaching us. Cell 1994; 77: 627–38.
13. Tessarollo L Vogel KS Palko ME Reid SW Parada LF. Targeted mutation in the neurotrophin-3 gene results in lossof muscle sensory neurons. Proc Natl Acad Sci U SA 1994; 91: 11844–8.
14. Liu X Ernfors P Wu H Jaenisch R. Sensory but not motor neuron deficits in mice lacking NT4 andBDNF. Nature 1995; 375: 2–41.
15. Jones KR Farinas I Backus C Reichardt LF. Targeted disruption of the BDNF gene perturbs brain andsensory neuron development but not motor neuron development. Cell 1994; 76: 989–99.
16. Farinas I Jones KR Backus C, et al Severe sensory and sympathetic deficits in mice lackingneurotrophin-3. Nature 1994; 369: 658–61.
17. Crowley C Spencer SD Nishimura MC, et al Mice lacking nerve growth factor display perinatal loss ofsensory and sympathetic neurons yet develop basal forebrain cholinergicneurons. Cell 1994; 76: 1001–11.
18. Conover JC Erickson JT Katz DM, et al Neuronal deficits, not involving motor neurons, in mice lacking BDNF and/or NT4. Nature 1995; 375: 235–8.
19. Henderson CE. Role of neurotrophic factors in neuronaldevelopment. Curr Opin Neurobiol 1996; 6: 64–70.
20. Schwartz PM Borghesani PR Levy RL, et al Abnormal cerebellar development and foliation in BDNF-/- micereveals a role for neurotrophins in CNS patterning. Neuron 1997; 19: 269–81.
21. Kokaia M Asztely F Olofsdotter K, et al Endogenous neurotrophin-3 regulates short-term plasticity atlateral perforant path-granule cell synapses. JNeurosci 1998; 18: 8730–9.
22. Kromer LF. Nerve growth factor treatment after brain injury preventsneuronal death. Science 1987; 235: 214–6.
23. Rosenberg MB Friedmann T Robertson RC, et al Grafting genetically modified cells to the damaged brain:Restorative effects of NGF expression. Science 1988; 242: 1575–8.
24. Koliatsos VE Nauta HJ Clatterbuck RE, et al Mouse nerve growth factor prevents degeneration of axotomizedbasal forebrain cholinergic neurons in the monkey. JNeurosci 1990; 10: 3801–13.
25. Tuszynski MH Sang H Yoshida K Gage FH. Recombinant human nerve growth factor infusions preventcholinergic neuronal degeneration in the adult primatebrain. Ann Neurol 1991; 30: 625–36.
26. Mitsumoto H Ikeda K Klinkosz B, et al Arrest of motor neuron disease in wobbler mice cotreated withCNTF and BDNF [see comments). Science 1994; 265: 1107–10.
27. Tuszynski MH Mafong E Meyer S. Central infusions of brain-derived neurotrophic factor andneurotrophin- 4/5, but not nerve growth factor and neurotrophin-3, preventloss of the cholinergic phenotype in injured adult motorneurons. Neuroscience 1996; 71: 761–71.
28. Tuszynski MH Roberts J Senut MC, et al Gene therapy in the adult primate brain: Intraparenchymal graftsof cells genetically modified to produce nerve growth factor preventcholinergic neuronal degeneration. GeneTher 1996; 3: 305–14.
29. Tuszynski MH Grill RJ Blesch A. Spinal cord regeneration. In: Tuszynski MH Kordower J,eds. CNS regeneration: Basic science and clinical advances. San Diego: Academic Press, 1999: 605–29.
30. Gage FH Fisher LJ Jinnah HA, et al Grafting genetically modified cells to the brain: Conceptual andtechnical issues. Prog Brain Res 1990; 82: 1–10.
31. Whittcmore SR Eaton MJ Onifer SM. Gene therapy and the use of stem cells for central nervoussystem regeneration. Adv Neurol 1997; 72: 113–9.
32. Breakefield X Jacobs A Wang S. Genetic engineering for CNS regeneration. In: Tuszynski MH Kordower J,eds. CNS regeneration: Basic science and clinical advances. San Diego: Academic Press, 1999: 251–91.
33. Suhr ST Gage FH. Gene therapy in the central nervous system: The use ofrecombinant retroviruses. Arch Neurol 1999; 56: 287–92.
34. Tuszynski MH Peterson DA Ray J, et al Fibroblasts genetically modified to produce nerve growth factorinduce robust neuritic ingrowth after grafting to the spinalcord. Exp Neurol 1994; 126: 1–14.
35. Nakahara Y Gage FH Tuszynski MH. Grafts of fibroblasts genetically modified to secrete NGF,BDNF, NT-3, or basic FGF elicit differential responses in the adult spinalcord. Cell Transplant 1996; 5: 191–204.
36. Tuszynski MH Gabriel K Gage FH, et al Nerve growth factor delivery by gene transfer inducesdifferential outgrowth of sensory, motor, and noradrenergic neurites afteradult spinal cord injury. Exp Neurol 1996; 137: 157–73.
37. Grill R Blesch A Tuszynski MH. Robust growth of chronically injured spinal cord axonsinduced by grafts of genetically modified NGF-secretingcells. Exp Neurol 1997; 148: 444–52.
38. Kim DH Gutin PH Noble LJ, et al Treatment with genetically engineered fibroblasts producing NGFor BDNF can accelerate recovery from traumatic spinal cord injury in theadult rat. Neuroreport 1996; 7: 2221–5.
39. Tuszynski MH Murai K Blesch A, et al Functional characterization of NGF-secreting cell grafts to theacutely injured spinal cord. CellTransplant 1997; 6: 361–8.
40. Ramer MS Priestley JV McMahon SB. Functional regeneration of sensory axons into the adultspinal cord [see comments]. Nature 2000; 403: 312–6.
41. Apfel SC Wright DE Wiideman AM, et al Nerve growth factor regulates the expression of brain-derivedneurotrophic factor mRNA in the peripheral nervous system. Mol Cell Neurosci 1996; 7: 134–42.
42. Kobayashi NR Fan DP Giehl KM, et al BDNF and NT-4/5 prevent atrophy of rat rubrospinal neurons aftercervical axotomy, stimulate GAP-43 and Talphal-tubulin mRNA expression, andpromote axonal regeneration. J Neurosci 1997; 17: 9583–95.
43. Liu Y Kim D Himes BT, et al Transplants of fibroblasts genetically modified to express BDNFpromote regeneration of adult rat rubrospinal axons and recovery of forelimbfunction. J Neurosci 1999; 19: 4370–87.
44. Lu P Blesch A Low K Tuszynski MH. Cellular delivery of BDNF promotes both motor and sensoryaxonal growth after spinal cord injury. Soc Neurosci Abstr 1999; 25: 498.
45. Schnell L Schneider R Kolbeck R, et al Neurotrophin-3 enhances sprouting of corticospinal tract duringdevelopment and after adult spinal cord lesion [seecomments]. Nature 1994; 367: 170–3.
46. Bradbury EJ Khemani S Von R, et al NT-3 promotes growth of lesioned adult rat sensory axonsascending in the dorsal columns of the spinal cord. Eur J Neurosci 1999; 11: 3873–83.
47. Zhang Y Dijkhuizen PA Anderson PN, et al NT-3 delivered by an adenoviral vector induces injured dorsalroot axons to regenerate into the spinal cord of adult rats. J Neurosci Res 1998; 54: 554–62.
48. Xu XM Guenard V Kleitman N, et al A combination of BDNF and NT-3 promotes supraspinal axonalregeneration into Schwann cell grafts in adult rat thoracic spinalcord. Exp Neurol 1995; 134: 261–72.
49. Blesch A Diergardt N Uy HS Tuszynski MH. Cellularly delivered NT-4/5 has axonal growth promotingeffects in the injured adult rat spinal cord. SocNeurosci Abstr 1999; 25: 497.
50. Ikebuchi K Wong GG Clark SC, et al Interleukin 6 enhancement of interleukin 3-dependentproliferation of multipotential hemopoietic progenitors. Proc Natl Acad Sci U S A 1987; 84: 9035–9.
51. Rennick D Jackson J Yang G, et al Interleukin-6 interacts with interleukin-4 and otherhematopoietic growth factors to selectively enhance the growth ofmegakaryocytic, erythroid, myeloid, and multipotential progenitorcells. Blood 1989; 73: 1828–35.
52. Bazan JF. Neuropoietic cytokines in the hematopoieticfold. Neuron 1991; 7: 197–208.
53. Bernad A Kopf M Kulbacki R, et al Interleukin-6 is required in vivo for the regulation of stemcells and committed progenitors of the hematopoietic system. Immunity 1994; 1: 725–31.
54. Fann MJ Patterson PH. Neuropoietic cytokines and activin A differentially regulatethe phenotype of cultured sympathetic neurons. ProcNatl Acad Sci U S A 1994; 91: 43–7.
55. Mehler MF Marmur R Gross R, et al Cytokines regulate the cellular phenotype of developing neurallineage species. Int J Dev Neurosci 1995; 13: 213–40.
56. Bonni A Sun Y Nadal-Vicens M, et al Regulation of gliogenesis in the central nervous system by theJAK-STAT signaling pathway. Science 1997; 278: 477–83.
57. Koblar SA Turnley AM Classon BJ, et al Neural precursor differentiation into astrocytes requiressignaling through the leukemia inhibitory factor receptor. Proc Natl Acad Sci U S A 1998; 95: 3178–81.
58. Ip NY. The neurotrophins and neuropoietic cytokines: Two families ofgrowth factors acting on neural and hematopoietic cells. Ann N Y Acad Sci 1998; 840: 97–106.
59. Galli R Pagano SF Gritti A Vescovi AL. Regulation of neuronal differentiation in human CNS stem cellprogeny by leukemia inhibitory factor. DevNeurosci 2000; 22: 86–95.
60. Arakawa Y Sendtner M Thoenen H. Survival effect of ciliary neurotrophic factor (CNTF) onchick embryonic motoneurons in culture: Comparison with other neurotrophicfactors and cytokines. J Neurosci 1990; 10: 3507–15.
61. Sendtner M Stockli KA Thoenen H. Synthesis and localization of ciliary neurotrophic factor inthe sciatic nerve of the adult rat after lesion and duringregeneration. J Cell Biol 1992; 118: 139–48.
62. Martinou JC Martinou I Kato AC. Cholinergic differentiation factor (CDF/LIF) promotessurvival of isolated rat embryonic motoneurons in vitro. Neuron 1992; 8: 737–44.
63. Maeda Y Matsumoto M Hori O, et al Hypoxia/reoxygenation-mediated induction of astrocyte interleukin6: A paracrine mechanism potentially enhancing neuronsurvival. J Exp Med 1994; 180: 2297–308.
64. Kotzbauer PT Lampe PA Estus S, et al Postnatal development of survival responsiveness in ratsympathetic neurons to leukemia inhibitory factor and ciliary neurotrophicfactor. Neuron 1994; 12: 763–73.
65. Horton AR Barlett PF Pennica D Davies AM. Cytokines promote the survival of mouse cranial sensoryneurones at different developmental stages. Eur JNeurosci 1998; 10: 673–9.
66. Toulmond S Vige X Fage D Benavides J. Local infusion of interleukin-6 attenuates the neurotoxiceffects of NMDA on rat striatal cholinergic neurons. Neurosci Lett 1992; 144: 49–52.
67. Akaneya Y Takahashi M Hatanaka H. Interleukin-1 beta enhances survival and interleukin-6protects against MPP+ neurotoxicity in cultures of fetal ratdopaminergic neurons. Exp Neurol 1995; 136: 44–52.
68. Ikeda K Kinoshita M Tagaya N, et al Coadministration of interleukin-6 (IL-6) and soluble IL-6receptor delays progression of wobbler mouse motor neurondisease. Brain Res 1996; 726: 91–7.
69. Gravel C Gotz R Lorrain A Sendtner M. Adenoviral gene transfer of ciliary neurotrophic factor andbrain-derived neurotrophic factor leads to long-term survival of axotomizedmotor neurons. Nat Med 1997; 3: 765–70.
70. Yoshida K Taga T Saito M, et al Targeted disruption of gp130, a common signal transducer for theinterleukin 6 family of cytokines, leads to myocardial and hematologicaldisorders. Proc Natl Acad Sci U S A 1996; 93: 407–11.
71. Nakashima K Wiese S Yanagisawa M, et al Developmental requirement of gp130 signaling in neuronal survivaland astrocyte differentiation. J Neurosci 1999; 19: 5429–34.
72. Banner LR Patterson PH. Major changes in the expression of the mRNAs for cholinergicdifferentiation factor/leukemia inhibitory factor and its receptor afterinjury to adult peripheral nerves and ganglia. ProcNatl Acad Sci U S A 1994; 91: 7109–13.
73. Hirota H Kiyama H Kishimoto T Taga T. Accelerated nerve regeneration in mice by upregulatedexpression of interleukin (IL) 6 and IL-6 receptor after trauma [seecomments]. J Exp Med 1996; 183: 2627–34.
74. Curtis R Scherer SS Somogyi R, et al Retrograde axonal transport of LIF is increased by peripheralnerve injury: Correlation with increased LIF expression in distalnerve. Neuron 1994; 12: 191–204.
75. Ye JH Houle JD. Treatment of the chronically injured spinal cord withneurotrophic factors can promote axonal regeneration from supraspinalneurons. Exp Neurol 1997; 143: 70–81.
76. Bregman BS McAtee M Dai HN Kuhn PL. Neurotrophic factors increase axonal growth after spinal cordinjury and transplantation in the adult rat. ExpNeurol 1997; 148: 475–94.
77. Blesch A Uy HS Grill RJ, et al Leukemia inhibitory factor augments neurotrophin expression andcorticospinal axon growth after adult CNS injury. JNeurosci 1999; 19: 3556–66.
78. Campbell IL. Structural and functional impact of the transgenic expressionof cytokines in the CNS. Ann N Y Acad Sci 1998; 840: 83–96.
79. Lin LF Doherty DH Lile JD, et al GDNF: A glial cell line-derived neurotrophic factor for midbraindopaminergic neurons [see comments]. Science 1993; 260: 1130–2.
80. Henderson CE Phillips HS Pollock RA, et al GDNF: A potent survival factor for motoneurons present inperipheral nerve and muscle [see comments] [publishederratum appears in Science 1995; 267: 777]. Science 1994; 266: 1062–4.
81. Krieglstein K Suter-Crazzolara C Fischer WH Unsicker K. TGF-beta superfamily members promote survival of midbraindopaminergic neurons and protect them against MPP+toxicity. EMBO J 1995; 14: 736–42.
82. Oppenheim RW Houenou LJ Johnson JE, et al Developing motor neurons rescued from programmed andaxotomy-induced cell death by GDNF [see comments]. Nature 1995; 373: 344–6.
83. Yan Q Matheson C Lopez OT. In vivo neurotrophic effects of GDNF on neonatal and adultfacial motor neurons [see comments]. Nature 1995; 373: 341–4.
84. Hottinger AF Azzouz M Deglon N, et al Complete and long-term rescue of lesioned adult motoneurons bylentiviral-mediated expression of glial cell line-derived neurotrophicfactor in the facial nucleus. J Neurosci 2000; 20: 5587–93.
85. Blesch A Diergardt N Tuszynski MH. Cellularly delivered GDNF has robust chemotropic effects inthe non-injured and injured adult rat spinal cord. Soc Neurosci Abstr 1998; 24: 555.
86. Flanders KC Ren RF Lippa CF. Transforming growth factor-betas in neurodegenerativedisease. Prog Neurobiol 1998; 54: 71–85.
87. Cheng H Cao Y Olson L. Spinal cord repair in adult paraplegic rats: Partialrestoration of hind limb function [see comments]. Science 1996; 273: 510–3.
88. Teng YD Mocchetti I Wrathall JR. Basic and acidic fibroblast growth factors protect spinalmotor neurones in vivo after experimental spinal cordinjury. Eur J Neurosci 1998; 10: 798–802.
89. Lee TT Green BA Dietrich WD Yezierski RP. Neuroprotective effects of basic fibroblast growth factorfollowing spinal cord contusion injury in the rat. JNeurotrauma 1999; 16: 347–56.
90. Oudega M Xu XM Guenard V, et al A combination of insulin-like growth factor-I andplatelet-derived growth factor enhances myelination but diminishes axonalregeneration into Schwann cell grafts in the adult rat spinalcord. Glia 1997; 19: 247–58.
91. Ye P Carson J D'Ercole AJ. In vivo actions of insulin-like growth factor-I (IGF-I) onbrain myelination: Studies of IGF-I and IGF binding protein-1 (IGFBP-1)transgenic mice. J Neurosci 1995; 15: 7344–56.
92. Tuszynski MH Weidner N McCormack M, et al Grafts of genetically modified Schwann cells to the spinal cord:Survival, axon growth, and myelination. CellTransplant 1998; 7: 187–96.
93. Weidner N Blesch A Grill RJ Tuszynski MH. Nerve growth factor-hypersecreting Schwann cell graftsaugment and guide spinal cord axonal growth and remyelinate central nervoussystem axons in a phenotypically appropriate manner that correlates withexpression of L1. J Comp Neurol 1999; 413: 495–506.
94. Ramon-Cueto A Avila J. Olfactory ensheathing glia: Properties andfunction. Brain Res Bull 1998; 46: 175–87.
95. Ramon-Cueto A Cordero MI Santos-Benito FF Avila J. Functional recovery of paraplegic rats and motor axonregeneration in their spinal cords by olfactory ensheathingglia. Neuron 2000; 25: 425–35.
96. Alvarez-Buylla A Lois C. Neuronal stem cells in the brain of adultvertebrates. Stem Cells 1995; 13: 263–72.
97. Gage FH Coates PW Palmer TD, et al Survival and differentiation of adult neuronal progenitor cellstransplanted to the adult brain. Proc Natl Acad SciU S A 1995; 92: 11879–83.
98. Weiss S Reynolds BA Vescovi AL, et al Is there a neural stem cell in the mammalian forebrain?[see comments]. Trends Neurosci 1996; 19: 387–93.
99. Martinez-Serrano A Bjorklund A. Immortalized neural progenitor cells for CNS gene transferand repair. Trends Neurosci 1997; 20: 530–8.
100. Heumann R Korsching S Bandtlow C Thoenen H. Changes of nerve growth factor synthesis in nonneuronal cellsin response to sciatic nerve transection. J CellBiol 1987; 104: 1623–31.
101. Acheson A Barker PA Alderson RF, et al Detection of brain-derived neurotrophic factor-like activity infibroblasts and Schwann cells: Inhibition by antibodies toNGF. Neuron 1991; 7: 265–75.
102. Friedman B Scherer SS Rudge JS, et al Regulation of ciliary neurotrophic factor expression inmyelin-related Schwann cells in vivo. Neuron 1992; 9: 295–305.
103. Meyer M Matsuoka I Wetmore C, et al Enhanced synthesis of brain-derived neurotrophic factor in thelesioned peripheral nerve: Different mechanisms are responsible for theregulation of BDNF and NGF mRNA. J CellBiol 1992; 119: 45–54.
104. Reynolds ML Woolf CJ. Reciprocal Schwann cell-axon interactions. Curr Opin Neurobiol 1993; 3: 683–93.
105. Bunge MB. Schwann cells regulation of extracellular matrix biosynthesisand assembly. In: Dyck PJ Thomas PK,eds. Peripheral neuropathy. Philadelphia: WBSaunders, 1993: 299–316.
106. Seilheimer B Schachner M. Regulation of neural cell adhesion molecule expression oncultured mouse Schwann cells by nerve growth factor. EMBO J 1987; 6: 1611–6.
107. Bixby JL Lilien J Reichardt LF. Identification of the major proteins that promote neuronalprocess outgrowth on Schwann cells in vitro. J CellBiol 1988; 107: 353–61.
108. Griffin JW Hoffman PN. Degeneration and regeneration in the peripheral nervoussystem. In: Dyck PJ Thomas PK,eds. Peripheral neuropathy. Philadelphia: WBSaunders, 1993: 361–76.
109. Brook GA Lawrence JM Shah B Raisman G. Extrusion transplantation of Schwann cells into the adult ratthalamus induces directional host axon growth. ExpNeurol 1994; 126: 31–43.
110. Richardson PM McGuinness UM Aguayo AJ. Axons from CNS neurons regenerate into PNSgrafts. Nature 1980; 284: 264–5.
111. Bunge MB. Transplantation of purified populations of Schwann cells intolesioned adult rat spinal cord. J Neurol 1994; 242: S36–9.
112. Li Y Raisman G. Schwann cells induce sprouting in motor and sensory axons inthe adult rat spinal cord. J Neurosci 1994; 14: 4050–63.
113. Xu XM Guenard V Kleitman N Bunge MB. Axonal regeneration into Schwann cell-seeded guidancechannels grafted into transected adult rat spinal cord. J Comp Neurol 1995; 351: 145–60.
114. Honmou O Felts PA Waxman SG Kocsis JD. Restoration of normal conduction properties in demyelinatedspinal cord axons in the adult rat by transplantation of exogenous Schwanncells. J Neurosci 1996; 16: 3199–208.
115. Xu XM Chen A Guenard V, et al Bridging Schwann cell transplants promote axonal regenerationfrom both the rostral and caudal stumps of transected adult rat spinalcord. J Neurocytol 1997; 26: 1–16.
116. Xu XM Zhang SX Li H, et al Regrowth of axons into the distal spinal cord through aSchwann-cell-seeded mini-channel implanted into hemisected adult rat spinalcord. Eur J Neurosci 1999; 11: 1723–40.
117. Levi AD. Characterization of the technique involved in isolating Schwann cells from adult human peripheral nerve. JNeurosci Methods 1996; 68: 21–6.
118. Casella GT Bunge RP Wood PM. Improved method for harvesting human Schwann cells frommature peripheral nerve and expansion in vitro. Glia 1996; 17: 327–38.
119. Casella GT Wieser R Bunge RP, et al Density dependent regulation of human Schwann cellproliferation. Glia 2000; 30: 165–77.
120. Graziadei PP Graziadei Monti GA. Neurogenesis andneuron regeneration in the olfactory system of mammals. III. Deafferentationand reinnervation of the olfactory bulb following section of the filaolfactoria in rat. J Neurocytol 1980; 9: 145–62.
121. Doucette JR Kiernan JA Flumcrfelt BA. The re-innervation of olfactory glomeruli followingtransection of primary olfactory axons in the central or peripheral nervoussystem. J Anat 1983; 137: 1–19.
122. Graziadei PP Graziadei Monti GA. Neuronal changes inthe forebrain of mice following penetration by regenerating olfactoryaxons. J Comp Neurol 1986; 247: 344–56.
123. Cancalon PF. Survival and subsequent regeneration of olfactory neuronsafter a distal axonal lesion. J Neurocytol 1987; 16: 829–41.
124. Gong Q Bailey MS Pixley SK, et al Localization and regulation of low affinity nerve growth factorreceptor expression in the rat olfactory system during development andregeneration. J Comp Neurol 1994; 344: 336–48.
125. Raisman G. Specialized neuroglial arrangement may explain the capacityof vomeronasal axons to reinnervate central neurons. Neuroscience 1985; 14: 237–54.
126. Valverde F Lopez-Mascaraque L. Neuroglial arrangements in the olfactory glomeruli of thehedgehog. J Comp Neurol 1991; 307: 658–74.
127. Ramon-Cueto A Valverde F. Olfactory bulb ensheathing glia: A unique cell type withaxonal growth-promoting properties. Glia 1995; 14: 163–73.
128. Pasterkamp RJ De Winter F Giger RJ Verhaagen J. Role for semaphorin III and its receptor neuropilin-1 inneuronal regeneration and scar formation? Prog Brain Res 1998; 117: 151–70.
129. Ramon-Cueto A Nieto-Sampedro M. Regeneration into the spinal cord of transected dorsal rootaxons is promoted by ensheathing glia transplants. Exp Neurol 1994; 127: 232–44.
130. Navarro X Valero A Gudino G, et al Ensheathing glia transplants promote dorsal root regeneration andspinal reflex restitution after multiple lumbar rhizotomy. Ann Neurol 1999; 45: 207–15.
131. Li Y Field PM Raisman G. Repair of adult rat corticospinal tract by transplants ofolfactory ensheathing cells [see comments]. Science 1997; 277: 2000–2.
132. Li Y Field PM Raisman G. Regeneration of adult rat corticospinal axons induced bytransplanted olfactory ensheathing cells. JNeurosci 1998; 18: 10514–24.
133. Gage FH Ray J Fisher LJ. Isolation, characterization, and use of stem cells from theCNS. Annu Rev Neurosci 1995; 18: 159–92.
134. Suhonen JO Peterson DA Ray J Gage FH. Differentiation of adult hippocampus-derived progenitors intoolfactory neurons in vivo. Nature 1996; 383: 624–7.
135. McDonald JW Liu XZ Qu Y, et al Transplanted embryonic stem cells survive, differentiate andpromote recovery in injured rat spinal cord. NatMed 1999; 5: 1410–2.
136. Liu S Qu Y Stewart TJ, et al Embryonic stem cells differentiate into oligodendrocytes andmyelinate in culture and after spinal cord transplantation. Proc Natl Acad Sci U S A 2000; 97: 6126–31.
137. Azizi SA Stokes D Augelli BJ, et al Engraftment and migration of human bone marrow stromal cellsimplanted in the brains of albino rats—similarities to astrocytegrafts. Proc Natl Acad Sci U S A 1998; 95: 3908–13.
138. Kopen GC Prockop DJ Phinney DG. Marrow stromal cells migrate throughout forebrain andcerebellum, and they differentiate into astrocytes after injection intoneonatal mouse brains. Proc Natl Acad Sci U SA 1999; 96: 10711–6.
139. Woodbury D Schwarz EJ Prockop DJ Black IB. Adult rat and human bone marrow stromal cells differentiateinto neurons. J Neurosci Res 2000; 61: 364–70.